CVRX — CVRx, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1235912 ·
Last close
$2.70
Market Cap
$71.93M
52W High
$11.30
52W Low
$2.20
ADV30
714,803
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 15,705,000 | 13,724,000 | -13,023,000 | -14,044,000 | 92,283,000 | 64,586,000 | 72,330,000 |
| Mar 2026 | 14,769,000 | 12,881,000 | -12,161,000 | -13,120,000 | 99,728,000 | 72,303,000 | 70,619,000 |
| Dec 2025 | 16,024,000 | 13,825,000 | -11,184,000 | -11,934,000 | 104,794,000 | 75,708,000 | 65,470,000 |
| Sep 2025 | 14,690,000 | 12,753,000 | -12,268,000 | -12,870,000 | 111,325,000 | 85,124,000 | 63,271,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-40,457,000
Investing CF
$-597,000
Financing CF
$10,616,000
CapEx
$-597,000
Dividends Paid
—
Buybacks
$-43,000
EPS Diluted TTM
$-1.98
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-617,816,000
Inventory
$13,028,000
Receivables
$9,401,000
ST Investments
—
EBIT TTM
$-45,948,000
Pretax Income TTM
$-51,974,000
Interest Exp TTM
$6,026,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$61,188,000
EBITDA
$-47,843,000
Free Cash Flow
$-23,801,750
Enterprise Value
$71,531,800
Total Cash
$64,586,000
Total Debt
$59,390,000
Shares Out
26,641,597
Trailing EPS
$-1.97
Book Value
$0.75
ROE
-133.4%
ROA
-28.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 56,651,000 | -51,265,000 | -53,306,000 | 104,794,000 | 65,470,000 | 39,324,000 | -40,170,000 |
| Dec 2024 | 51,292,000 | -59,490,000 | -59,965,000 | 133,414,000 | 62,359,000 | 71,055,000 | -39,144,000 |
| Dec 2023 | 39,295,000 | -43,103,000 | -41,199,000 | 115,229,000 | 39,282,000 | 75,947,000 | -39,021,000 |
| Dec 2022 | 22,469,000 | -42,527,000 | -41,428,000 | 124,937,000 | 15,757,000 | 109,180,000 | -42,677,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.88
Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)
max pain strike: $2.50 · spot: $2.62 · call volume: 3 · put volume: 431
Expected Move to 2027-01-15:
±$0.90
(34.35%) —
implied range
$1.72 –
$3.52
· ATM straddle on $2.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HYPR | Hyperfine, Inc. | $73.98M | $0.81 | — |
| RNXT | RenovoRx, Inc. | $74.91M | $1.66 | — |
| RTGN | RetinalGenix Technologies Inc. | $75.19M | $3.99 | — |
| GUTS | FRACTYL HEALTH, INC. | $77.36M | $0.49 | — |
| DRIO | DarioHealth Corp. | $64.97M | $6.63 | — |
News headlines (Yahoo Finance, 1h cache)
CVRx Appoints John Landry as Chief Financial Officer
2026-09-21 20:07 · Yahoo
CVRx Responds to Letter from Pointillist Family Office
2026-08-25 12:00 · Yahoo
CVRx Announces Devoted Health Medicare Advantage Coverage Policy for Barostim Therapy
2026-08-24 12:30 · Yahoo
CVRx (CVRX) Q2 2026 Earnings Call Transcript
2026-08-13 22:15 · Yahoo
CVRx Announces Sales Leadership Transition
2026-08-11 11:00 · Yahoo
CVRx Inc (CVRX) (Q2 2026) Earnings Call Highlights: Sales Execution Challenges Offset Strong ...
2026-08-07 05:08 · Yahoo
CVRx (CVRX) Reports Q2 Loss, Beats Revenue Estimates
2026-08-07 02:35 · Yahoo
CVRx Q2 Earnings Call Highlights
2026-08-07 01:03 · Yahoo
Compared to Estimates, CVRx (CVRX) Q2 Earnings: A Look at Key Metrics
2026-08-07 00:00 · Yahoo
CVRx Reports Second Quarter 2026 Financial and Operating Results
2026-08-06 20:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.